Kirschner P, Teske A, Schröder K H, Kroppenstedt R M, Wolters J, Böttger E C
Institut für Medizinische Mikrobiologie, Medizinische Hochschule Hannover, Germany.
Int J Syst Bacteriol. 1992 Apr;42(2):257-62. doi: 10.1099/00207713-42-2-257.
A new rapidly growing mycobacterium was isolated from human sputum. This organism grew at 22, 31, 37, and 41 degrees C and possessed catalase, acid phosphatase, acetamidase, urease, nicotinamidase, pyrazinamidase, and nitrate reductase activities. It did not produce nicotinic acid, hydrolyze Tween, or have benzamidase, isonicotinamidase, succinidamidase, and arylsulfatase activities. A mycolic acid analysis revealed a simple, unique pattern. The organism is susceptible to antituberculotic drugs. A comparative 16S rRNA sequence analysis placed this organism within the confines of the genus Mycobacterium, most closely related to the thermotolerant rapidly growing species. On the basis of the pattern of enzymatic activities and metabolic properties, as well as the unique 16S rRNA sequence, we propose that our single strain represents a new species, for which we propose the name Mycobacterium confluentis. The type strain is strain 1389/90; a culture of this strain has been deposited in the German Collection of Microorganisms and Cell Cultures as strain DSM 44017.
从人类痰液中分离出一种新的快速生长的分枝杆菌。该菌在22、31、37和41摄氏度下均可生长,并具有过氧化氢酶、酸性磷酸酶、乙酰胺酶、脲酶、烟酰胺酶、吡嗪酰胺酶和硝酸盐还原酶活性。它不产生烟酸,不水解吐温,也不具有苯甲酰胺酶、异烟酰胺酶、琥珀酰胺酶和芳基硫酸酯酶活性。分枝菌酸分析显示出一种简单独特的模式。该菌对抗结核药物敏感。通过比较16S rRNA序列分析,该菌被归入分枝杆菌属,与耐热快速生长的物种关系最为密切。基于酶活性和代谢特性模式以及独特的16S rRNA序列,我们提出我们的单一菌株代表一个新物种,我们将其命名为融合分枝杆菌。模式菌株为1389/90菌株;该菌株的培养物已作为DSM 44017菌株保藏于德国微生物和细胞培养物保藏中心。